Cargando…
Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF
In age-related macular degeneration (AMD) or diabetic retinopathy (DR), hypoxia and inflammatory processes lead to an upregulation of the vascular endothelial growth factor (VEGF) expression and thereby to pathological neovascularisation with incorrectly formed vessels prone to damage, thus increasi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098639/ https://www.ncbi.nlm.nih.gov/pubmed/32214330 http://dx.doi.org/10.1371/journal.pone.0230344 |
_version_ | 1783511218385846272 |
---|---|
author | Stumpf, Constanze Wimmer, Tobias Lorenz, Birgit Stieger, Knut |
author_facet | Stumpf, Constanze Wimmer, Tobias Lorenz, Birgit Stieger, Knut |
author_sort | Stumpf, Constanze |
collection | PubMed |
description | In age-related macular degeneration (AMD) or diabetic retinopathy (DR), hypoxia and inflammatory processes lead to an upregulation of the vascular endothelial growth factor (VEGF) expression and thereby to pathological neovascularisation with incorrectly formed vessels prone to damage, thus increasing the vascular permeability and the risk of bleeding and oedema in the retina. State of the art treatment is the repeated intraocular injection of anti-VEGF molecules. For developing improved individualized treatment approaches, a minimally invasive, repeatable method for in vivo quantification of VEGF in the eye is necessary. Therefore, we designed single molecule eBRET2 VEGF biosensors by directly fusing a Renilla luciferase mutant (Rluc8) N-terminal and a green fluorescent protein (GFP2) C-terminal to a VEGF binding domain. In total, 10 different VEGF biosensors (Re01- Re10) were generated based on either single domains or full length of VEGF receptor 1 or 2 extracellular regions as VEGF binding domains. Full length expression of the biosensors in HEK293-T cells was verified via Western Blot employing an anti-Rluc8-IgG. Expression of alternative splice variants was eliminated through the deletion of the donor splice site by introduction of a silent point mutation. In all ten biosensors the energy transfer from the Rluc8 to the GFP2 occurs and generates a measurable eBRET2 ratio. Four biosensors show a relevant change of the BRET ratio (ΔBR) after VEGF binding. Furthermore, each biosensor shows a unique detection range for VEGF quantification and especially Re06 and Re07 have a high sensitivity in the range of in vivo VEGF concentrations in the eye, previously measured by invasive methods. In conclusion, we generated several eBRET2 biosensors that are suitable for VEGF quantification in vitro and could identify two eBRET2 biosensors, which may be suitable for non-invasive in vivo VEGF quantification with an implantable device. |
format | Online Article Text |
id | pubmed-7098639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-70986392020-04-03 Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF Stumpf, Constanze Wimmer, Tobias Lorenz, Birgit Stieger, Knut PLoS One Research Article In age-related macular degeneration (AMD) or diabetic retinopathy (DR), hypoxia and inflammatory processes lead to an upregulation of the vascular endothelial growth factor (VEGF) expression and thereby to pathological neovascularisation with incorrectly formed vessels prone to damage, thus increasing the vascular permeability and the risk of bleeding and oedema in the retina. State of the art treatment is the repeated intraocular injection of anti-VEGF molecules. For developing improved individualized treatment approaches, a minimally invasive, repeatable method for in vivo quantification of VEGF in the eye is necessary. Therefore, we designed single molecule eBRET2 VEGF biosensors by directly fusing a Renilla luciferase mutant (Rluc8) N-terminal and a green fluorescent protein (GFP2) C-terminal to a VEGF binding domain. In total, 10 different VEGF biosensors (Re01- Re10) were generated based on either single domains or full length of VEGF receptor 1 or 2 extracellular regions as VEGF binding domains. Full length expression of the biosensors in HEK293-T cells was verified via Western Blot employing an anti-Rluc8-IgG. Expression of alternative splice variants was eliminated through the deletion of the donor splice site by introduction of a silent point mutation. In all ten biosensors the energy transfer from the Rluc8 to the GFP2 occurs and generates a measurable eBRET2 ratio. Four biosensors show a relevant change of the BRET ratio (ΔBR) after VEGF binding. Furthermore, each biosensor shows a unique detection range for VEGF quantification and especially Re06 and Re07 have a high sensitivity in the range of in vivo VEGF concentrations in the eye, previously measured by invasive methods. In conclusion, we generated several eBRET2 biosensors that are suitable for VEGF quantification in vitro and could identify two eBRET2 biosensors, which may be suitable for non-invasive in vivo VEGF quantification with an implantable device. Public Library of Science 2020-03-26 /pmc/articles/PMC7098639/ /pubmed/32214330 http://dx.doi.org/10.1371/journal.pone.0230344 Text en © 2020 Stumpf et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Stumpf, Constanze Wimmer, Tobias Lorenz, Birgit Stieger, Knut Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF |
title | Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF |
title_full | Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF |
title_fullStr | Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF |
title_full_unstemmed | Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF |
title_short | Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF |
title_sort | creation of different bioluminescence resonance energy transfer based biosensors with high affinity to vegf |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098639/ https://www.ncbi.nlm.nih.gov/pubmed/32214330 http://dx.doi.org/10.1371/journal.pone.0230344 |
work_keys_str_mv | AT stumpfconstanze creationofdifferentbioluminescenceresonanceenergytransferbasedbiosensorswithhighaffinitytovegf AT wimmertobias creationofdifferentbioluminescenceresonanceenergytransferbasedbiosensorswithhighaffinitytovegf AT lorenzbirgit creationofdifferentbioluminescenceresonanceenergytransferbasedbiosensorswithhighaffinitytovegf AT stiegerknut creationofdifferentbioluminescenceresonanceenergytransferbasedbiosensorswithhighaffinitytovegf |